The immune system remains seriously out-of-whack—in an inflammatory state of overactivation and impaired ...

The US government paused all foreign assistance in January 2025. This abrupt decision affected the delivery of life-saving ...

On January 6, 2026, OncoNano Medicine announced a research collaboration with Gilead Sciences to test its ON-BOARD ...

Now, Gilead has conducted an analysis of a phenomenon that can undermine all infectious disease therapies, including ...

For the first time since HIV was identified, early human trials are starting to show what long‑imagined “drug‑free control” of the virus might look like in practice. Instead of chasing a total ...

PARIS — Europe has the tools to reverse its HIV epidemic but is falling short of its 2025 targets, public health leaders warned at the European AIDS Clinical Society (EACS) 2025 Annual Meeting last ...

Dr. Toyin Nwafor of Gilead Sciences is working at the intersection of medical innovation and community engagement to address persistent disparities in HIV prevention, particularly among Black women.

A Northwestern Medicine study published in Nature Communications has revealed how HIV can protect infected cells by altering ...

The government should also encourage the private sector to import this drug so that Ugandans who can afford, should buy ...

The clearance rates for those coinfected with HIV and hepatitis C virus (HCV) are still higher than those with HCV alone. Direct-acting antivirals (DAAs) are a means of curing HCV with an efficacy of ...

Human immunodeficiency virus (HIV) is a viral infection that attacks our immune systems. Infection enters the body by contact with bodily fluids, such a blood and semen. The disease can be transmitted ...

Scientists have identified what they are calling an "Achilles heel" of the HIV/AIDS virus that may aid in developing a functional vaccine. Using complex mathematics that are also used in stock market ...